Celltrion to cancel 1.72 tln won in treasury shares to boost shareholder value | Yonhap News Agency

## Summary
OK SEOUL, April 1 (Yonhap) -- Celltrion Inc., a major South Korean biopharmaceutical company, said Wednesday it will cancel 1.72 trillion won (US$1.14 billion) worth of treasury shares this month as part of efforts to enhance shareholder value. The planned cancellation exceeds the combined 1.59 trillion won worth of treasury share cancellations carried out in 2024 and 2025. "The company has decided to proceed with the scheduled large-scale share cancellation on April 13 to strengthen shareholder value amid growing uncertainty in the global economy," a company official said. Korea to meet rising demand Celltrion wins 294.9 bln-won drug substance supply deal from global firm (LEAD) Celltrion's Q4 net more than doubles on expanded biosimilar lineup Keywords #Celltrion-stock cancellation Articles with issue keywords Most Liked (2nd LD) Han Kang's 'We Do Not Part' wins NBCC Award for haunting portrayal of trauma Paik Kun-woo, at 80, says 'Music chose me' (Movie Review) 'Salmokji: Whispering Water': mood runs deeper than plot (News Focus) Han Kang's NBCC win again spotlights art of translation (LEAD) BTS scores 7th No. 1 album on Billboard 200 with 'Arirang' Most Saved (2nd LD) Han Kang's 'We Do Not Part' wins NBCC Award for haunting portrayal of trauma (News Focus) Han Kang's NBCC win again spotlights art of translation Paik Kun-woo, at 80, says 'Music chose me' (Movie Review) 'Salmokji: Whispering Water': mood runs deeper than plot Liberal ex-prime minister to declare mayoral bid in conservative stronghold Most Viewed All Categories (LEAD) Lee urges bold measures to cope with concerns about energy situation, including emergency economic decree if needed Gov't proposes 26.2 tln-won extra budget to cushion impact of Middle East tensions Korean Air to enter emergency management mode over soaring fuel costs (LEAD) Trump calls on countries to 'go get your own oil' from Strait of Hormuz, or buy it from U.S. Korea Tass news agency's delegation in Pyongyang prev Celltrion to cancel 1.72 tln won in treasury shares to boost shareholder value Next Celltrion to cancel 1.72 tln won in treasury shares to boost shareholder value

## Article Content
Facebook
X
More
Pinterest
Linked in
Tumblr
Reddit
Facebook Messenger
Copy URL
URL is copied.
OK
SEOUL, April 1 (Yonhap) -- Celltrion Inc., a major South Korean biopharmaceutical company, said Wednesday it will cancel 1.72 trillion won (US$1.14 billion) worth of treasury shares this month as part of efforts to enhance shareholder value.
The company plans to cancel 9.11 million treasury shares, equivalent to about 4 percent of its outstanding shares, the company said in a press release.
The planned cancellation exceeds the combined 1.59 trillion won worth of treasury share cancellations carried out in 2024 and 2025.
"The company has decided to proceed with the scheduled large-scale share cancellation on April 13 to strengthen shareholder value amid growing uncertainty in the global economy," a company official said.
As for the 3.23 million treasury shares that will remain following the cancellation, Celltrion said it plans to use these shares strategically to support future growth, including mergers and acquisitions (M&A), development of new technologies and facility investments.
This image provided by Celltrion Inc. shows the company's corporate logo. (PHOTO NOT FOR SALE) (Yonhap)
kyongae.choi@yna.co.kr
(END)
Related Articles
Celltrion to invest 1.2 tln won in S. Korea to meet rising demand
Celltrion wins 294.9 bln-won drug substance supply deal from global firm
(LEAD) Celltrion's Q4 net more than doubles on expanded biosimilar lineup
Keywords
#Celltrion-stock cancellation
Articles with issue keywords
Most Liked
(2nd LD) Han Kang's 'We Do Not Part' wins NBCC Award for haunting portrayal of trauma
Paik Kun-woo, at 80, says 'Music chose me'
(Movie Review) 'Salmokji: Whispering Water': mood runs deeper than plot
(News Focus) Han Kang's NBCC win again spotlights art of translation
(LEAD) BTS scores 7th No. 1 album on Billboard 200 with 'Arirang'
Most Saved
(2nd LD) Han Kang's 'We Do Not Part' wins NBCC Award for haunting portrayal of trauma
(News Focus) Han Kang's NBCC win again spotlights art of translation
Paik Kun-woo, at 80, says 'Music chose me'
(Movie Review) 'Salmokji: Whispering Water': mood runs deeper than plot
Liberal ex-prime minister to declare mayoral bid in conservative stronghold
Most Viewed
All Categories
(LEAD) Lee urges bold measures to cope with concerns about energy situation, including emergency economic decree if needed
Gov't proposes 26.2 tln-won extra budget to cushion impact of Middle East tensions
Korean Air to enter emergency management mode over soaring fuel costs
(LEAD) Trump calls on countries to 'go get your own oil' from Strait of Hormuz, or buy it from U.S.
Declassified documents show N. Korea's strong backlash against growing S. Korea–China ties in mid-1990s
Most Viewed More
Most Viewed Photos
Tass news agency's delegation in Pyongyang
Tass news agency's delegation in Pyongyang
Indonesian president visits S. Korea
Tass news agency's delegation in Pyongyang
prev
Celltrion to cancel 1.72 tln won in treasury shares to boost shareholder value
Next
Celltrion to cancel 1.72 tln won in treasury shares to boost shareholder value

---

## Expert Analysis

### Merits
- Korea's strong backlash against growing S.

### Areas for Consideration
- Korea to meet rising demand Celltrion wins 294.9 bln-won drug substance supply deal from global firm (LEAD) Celltrion's Q4 net more than doubles on expanded biosimilar lineup Keywords #Celltrion-stock cancellation Articles with issue keywords Most Liked (2nd LD) Han Kang's 'We Do Not Part' wins NBCC Award for haunting portrayal of trauma Paik Kun-woo, at 80, says 'Music chose me' (Movie Review) 'Salmokji: Whispering Water': mood runs deeper than plot (News Focus) Han Kang's NBCC win again spotlights art of translation (LEAD) BTS scores 7th No. 1 album on Billboard 200 with 'Arirang' Most Saved (2nd LD) Han Kang's 'We Do Not Part' wins NBCC Award for haunting portrayal of trauma (News Focus) Han Kang's NBCC win again spotlights art of translation Paik Kun-woo, at 80, says 'Music chose me' (Movie Review) 'Salmokji: Whispering Water': mood runs deeper than plot Liberal ex-prime minister to declare mayoral bid in conservative stronghold Most Viewed All Categories (LEAD) Lee urges bold measures to cope with concerns about energy situation, including emergency economic decree if needed Gov't proposes 26.2 tln-won extra budget to cushion impact of Middle East tensions Korean Air to enter emergency management mode over soaring fuel costs (LEAD) Trump calls on countries to 'go get your own oil' from Strait of Hormuz, or buy it from U.S.

### Implications
- OK SEOUL, April 1 (Yonhap) -- Celltrion Inc., a major South Korean biopharmaceutical company, said Wednesday it will cancel 1.72 trillion won (US$1.14 billion) worth of treasury shares this month as part of efforts to enhance shareholder value.
- As for the 3.23 million treasury shares that will remain following the cancellation, Celltrion said it plans to use these shares strategically to support future growth, including mergers and acquisitions (M&A), development of new technologies and facility investments.
- Korea to meet rising demand Celltrion wins 294.9 bln-won drug substance supply deal from global firm (LEAD) Celltrion's Q4 net more than doubles on expanded biosimilar lineup Keywords #Celltrion-stock cancellation Articles with issue keywords Most Liked (2nd LD) Han Kang's 'We Do Not Part' wins NBCC Award for haunting portrayal of trauma Paik Kun-woo, at 80, says 'Music chose me' (Movie Review) 'Salmokji: Whispering Water': mood runs deeper than plot (News Focus) Han Kang's NBCC win again spotlights art of translation (LEAD) BTS scores 7th No. 1 album on Billboard 200 with 'Arirang' Most Saved (2nd LD) Han Kang's 'We Do Not Part' wins NBCC Award for haunting portrayal of trauma (News Focus) Han Kang's NBCC win again spotlights art of translation Paik Kun-woo, at 80, says 'Music chose me' (Movie Review) 'Salmokji: Whispering Water': mood runs deeper than plot Liberal ex-prime minister to declare mayoral bid in conservative stronghold Most Viewed All Categories (LEAD) Lee urges bold measures to cope with concerns about energy situation, including emergency economic decree if needed Gov't proposes 26.2 tln-won extra budget to cushion impact of Middle East tensions Korean Air to enter emergency management mode over soaring fuel costs (LEAD) Trump calls on countries to 'go get your own oil' from Strait of Hormuz, or buy it from U.S.

### Expert Commentary
This article covers celltrion, won, shares topics. Notable strengths include discussion of celltrion. Areas of concern are also raised. Readability: Flesch-Kincaid grade 0.0. Word count: 481.